MC5R — the exocrine receptor

The system's least-told chapter — the same signal at the body's surface glands, a quiet corner of the map still being read for the first time.

Tissue

Exocrine glands (sebaceous, lacrimal); immune cells

Key ligands

α-MSH, ACTH

Signalling

Gs → cAMP

Accessory protein

MRAP / MRAP2 can modulate

Gene

18p11.21

Function

Regulates exocrine secretion — notably sebum and lipid production — and contributes to immune modulation.

When it fails

Knockout models show defective sebaceous secretion and altered thermoregulation; human role still being mapped.

MC5R is the melanocortin family's generalist. Its messenger RNA shows up in a strikingly wide range of tissues, which long made its core function hard to name. The answer came from removing it: the defining role of MC5R is the control of exocrine glands.^[1] What has emerged since is a receptor that reads the same melanocortin signal at several of the body's peripheral outlets at once — glands, fuel stores, and immune cells.

The sebum signal

When the Mc5r gene is knocked out in mice, the animals develop a severe defect in water repulsion and thermoregulation, traced to reduced production of sebaceous lipids — the oily secretion that waterproofs fur and skin. The knockout also impairs other exocrine tissues, including the Harderian, lacrimal, and preputial glands: the Harderian gland no longer makes its stress-regulated porphyrins, and the lacrimal gland loses its melanocortin-driven protein secretion. One receptor, in other words, coordinates secretion across several gland types.^[2] Mechanistically MC5R behaves like its relatives — coupling to Gs and raising cyclic AMP — with α-MSH and ACTH as agonists.^[3]

The MC5R gene

The receptor was cloned in 1993 as the fifth and last member of the family, a 325-amino-acid protein encoded by a single intronless exon on chromosome 18 (18p11.21).^[4] Unlike MC1R, whose variants rewrite hair and skin colour, or MC4R, whose loss-of-function alleles are the commonest single-gene cause of obesity, MC5R has yielded no clean human phenotype. A systematic screen across diverse populations found one non-synonymous variant, Phe209Leu, that signals normally in the lab, and no MC5R mutations in people with acne, hidradenitis suppurativa, or sebaceous-gland tumours.^[5] The same study placed the receptor's expression in human skin: present in keratinocytes and in the epithelium of glands and hair follicles, absent from fibroblasts and melanocytes.^[5] MC5R is a receptor whose importance is written in what it does, not in what breaks when it varies.

A marker of the maturing sebocyte

The mouse story translates cleanly to human sebaceous glands, with a telling refinement. In human skin, MC5R is found only on differentiating, lipid-laden sebocytes — not on the basal, undifferentiated cells that give rise to them. Cultured human sebocytes show the same switch: no receptor until differentiation begins, then strong expression in cells packed with lipid granules.^[6] MC5R is, in effect, a marker of a sebocyte's maturity — the point at which it commits to making sebum — and the melanocortin signal that reaches it drives that lipid programme forward.

Turning sebum down

If MC5R pushes sebum up, blocking it should push sebum down, and the clearest test used human tissue. A small-molecule antagonist of MC1R and MC5R, JNJ-10229570, dose-dependently cut sebaceous-lipid production in cultured human sebocytes; applied topically to human skin grafted onto immunodeficient mice, it shrank the sebaceous glands, reduced sebum-specific lipids, and lowered a marker of sebaceous differentiation.^[7] That is the strongest evidence that MC5R is a workable lever on human sebum, and it is why the receptor is watched for acne and other sebum-driven conditions. It has not yet produced an approved drug, and the antagonist's MC1R activity is a reminder that dialling one receptor without touching its pigment-controlling cousin is part of the challenge — the same selectivity problem this site maps for MC1R.

Fuel at the periphery

The central melanocortin receptors decide how much energy the body acquires and how it is spent (see MC4R and MC3R). MC5R appears to act at the far end of that chain, in the tissues that burn and store fuel. In skeletal muscle, α-MSH raises fatty-acid oxidation in a dose-dependent way through a cyclic AMP–protein kinase A–AMPK cascade, and silencing MC5R abolishes the effect.^[8] The same peptide also promotes glucose uptake into muscle through MC5R, which is part of why circulating α-MSH lowers blood glucose.^[9] In fat cells, α-MSH signalling through MC5R drives lipolysis — the release of stored triglyceride as glycerol and free fatty acids — via the lipases and perilipin that protein kinase A activates.^[10] Taken together these findings sketch a peripheral arm of the melanocortin system that mobilises and burns fuel, mirroring the central arm that curbs intake. The evidence is largely from mice and cell culture; how much it contributes to human metabolism is an open and interesting question.

Standing the immune system down

Beyond the sebaceous gland, MC5R turns up on immune cells — B and T lymphocytes among them — where melanocortin signalling helps regulate the inflammatory response.^[3] Its best-characterised immune job comes from the eye. After experimental autoimmune uveitis resolves in mice, the spleen holds a population of regulatory antigen-presenting cells that induce the FoxP3⁺ regulatory T cells which protect against a second attack. That protection depends on MC5R: mice lacking it fail to expand those cells and lose the post-disease tolerance, with the adenosine A2A receptor on T cells completing the circuit.^[11] It places MC5R inside the melanocortin system's broad pro-resolving reach, and it is one reason the receptor is studied as a target in autoimmune and inflammatory disease.

The receptor in three dimensions

MC5R was the last of the five to be seen. In 2023, cryo-EM structures of the human receptor bound to α-MSH and to the potent selective agonist PG-901, each coupled to Gs, showed the familiar family fold: the peptide's His-Phe-Arg-Trp motif in a U-shaped conformation, buried in a wide-open pocket.^[12] The comparison with MC3R in the same study is the useful part. γ-MSH's C-terminus reaches into an MC3R-specific groove that helps explain its preference for that subtype, whereas α-MSH's C-terminus barely touches MC5R at all — a hint that the receptor's selectivity is decided by subtler features of the pocket than the peptide tail. See the structural biology page for the whole family and the binding matrix for the affinities.

Why MC5R is watched

The therapeutic interest cuts several ways. In the skin, an MC5R antagonist that turns sebaceous output down is an appealing idea for acne; in the immune system, MC5R agonism is explored for a calming, resolving effect on inflammation; and in metabolism, its peripheral fuel-burning effects are being read for what they might add to the central appetite story.^[3]None of this has produced an approved drug, and MC5R remains the least pinned-down of the five — but it reads as a genuine frontier rather than a closed chapter.

For how MC5R fits the broader system, see the overview pillar; the related skin receptor is MC1R.

← Back to all receptors